Learn the most up-to-date and comprehensive information on oral therapies in lymphoma and chronic lymphocytic leukemia (CLL) by tuning in to a podcast featuring UVA Cancer Center Chief of the Division of Hematology/Oncology Michael E. Williams, MD, ScM.
Category: Cancer (Page 8)
A graduate of UVA, Greene returns to after 20 years on the West Coast. Learn more about her plans to further develop the prostate cancer program at UVA and find out what her research has uncovered for mitigating physician burnout.
With the addition of more specialty providers and expanded services, such as clinical trials and stem cell transplants, UVA Cancer Center is making improvements to better accommodate a greater number of patients.
To ensure the best outcome, in terms of both disease eradication and preserving the appearance and functionality of the eye, UVA brought together skilled providers from dermatopathology, dermatologic surgery and ophthalmology.
CAR T-cell therapy was just approved by the U.S. Food and Drug Administration for commercial use in adult patients with refractory and relapsed lymphoma.
BRCA isn't the only gene mutation linked to breast cancer. With large-panel genetic testing, UVA genetic counselors can better determine who is at greatest risk.
Low-dose CT lung cancer screening has the ability to reduce lung cancer mortality by 20 percent compared to chest X-ray. Unfortunately only around 4 to 6% of people eligible for lung cancer screening are actually getting screened.
Read a case study that demonstrates the impact of the UVA-Riverside partnership as the two centers continue to provide patients in the Tidewater area and beyond access to the latest in radiosurgical technology.
Kara Romano, MD, is part of a team at UVA pioneering new radiologic approaches to treating gynecologic and other cancers.
UVA offers an updated, more conformal version of the recommended combination therapy, which includes high-dose rate brachytherapy, intensity-modulated radiation therapy and use of a prostate-rectal spacer.